about
Epidemiology of neurodegeneration in American-style professional football playersTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderA Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsStem Cell Therapy for Treatment of Ocular DisordersGeneration of diverse neural cell types through direct conversionPluripotent stem cells models for Huntington's disease: prospects and challengesSensitive Tumorigenic Potential Evaluation of Adult Human Multipotent Neural Cells Immortalized by hTERT Gene TransductionProspects for replacement of auditory neurons by stem cells.Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer's disease mice.Targeting β-secretase with RNAi in neural stem cells for Alzheimer's disease therapy.Striatal morphology as a biomarker in neurodegenerative disease.The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population.Information theoretical analysis of aging as a risk factor for heart diseaseAlzheimer's disease in a dish: promises and challenges of human stem cell models.Mechanisms of human amniotic epithelial cell transplantation in treating stage III pressure ulcer in a rat model.Developments in intracerebral stem cell grafts.Regression modeling to inform cell incorporation into therapies for craniosynostosis.Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease.Emerging therapies for mitochondrial disorders.Nutraceuticals against Neurodegeneration: A Mechanistic Insight.Effects of intravenous human umbilical cord blood CD34+ stem cell therapy versus levodopa in experimentally induced Parkinsonism in mice.Combining topographical and genetic cues to promote neuronal fate specification in stem cells.Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.Frontotemporal dementia as a frontostriatal disorder: neostriatal morphology as a biomarker and structural basis for an endophenotype.The voyage of stem cell toward terminal differentiation: a brief overview.Modulating metals as a therapeutic strategy for Alzheimer's disease.In vivo tracking techniques for cellular regeneration, replacement, and redirection.Progress in stem cell therapy for major human neurological disorders.Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery.Adult human neural stem cell therapeutics: Current developmental status and prospectRole of MicroRNA Let-7 in Modulating Multifactorial Aspect of Neurodegenerative Diseases: an Overview.Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy.Human Dental Pulp Cells Differentiate toward Neuronal Cells and Promote Neuroregeneration in Adult Organotypic Hippocampal Slices In Vitro.Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches.Stem cells and stroke-how glowing neurons illuminate new paths.Hippocampal neuronal metal ion imbalance related oxidative stress in a rat model of chronic aluminum exposure and neuroprotection of meloxicam.Protein aggregation, misfolding and consequential human neurodegenerative diseases.Cell replacement therapy is the remedial solution for treating Parkinson's disease.Impact of hippocampal neuronal ablation on neurogenesis and cognition in the aged brain.
P2860
Q23912767-D9818E69-7972-47DF-B145-F63F92131AE0Q24626017-572F9EE2-2C30-4EF3-8C8C-0A412A3DAF10Q26746033-7267BBC9-561F-43FE-8D6E-ABD1A7BAA1F0Q26746974-6273E9B3-CC7E-46C6-ABAD-CDD14019B30DQ26765258-9F40E287-9D15-45C0-8946-BD92594223F2Q26860151-93CA8E7C-CAB6-4844-92D0-44ACE135FAFAQ27335199-41F2F749-A5E7-492D-B9C0-BB88145AB769Q30442282-CBA55607-F704-4DBF-A78D-9D024DB769F5Q34096125-50658652-3D98-4FA5-9637-C9A278809319Q34153594-C479B7CD-76EE-4CDE-B5E0-1B4FE7E97DBEQ34268646-BE430BAD-7FC7-4F05-874C-F57E172BBDEFQ35013326-F9E04840-BE52-4F6E-811E-40B3F074CAB1Q35636879-E90C8EFC-B978-488D-BFCF-A8436C835429Q36283888-5A4A844E-4246-4E18-AC57-CF975B51A670Q36335316-4FF2F075-E3AE-489C-B589-80A89B38E609Q36377595-895EC943-CCBE-4441-B3DC-F6FD06F0F8AEQ36584237-6CBF30C1-5090-4855-837D-BEF1F204170AQ36728537-AB7147AE-0D85-4DBB-B6BA-A8EFE34230D0Q36967723-6A7F0AAC-4E07-4A7A-B4F9-F1B67979907CQ37168739-9A822270-88CE-4949-B7F9-DD117403FBB5Q37517917-92A3543A-17FA-4A01-9690-A0FC15FD80D5Q37712549-75971D37-827D-47F6-8387-5ADC5B15EAE4Q37734609-4218F826-A5B9-419A-A88D-077ECB8BB522Q37987327-AFD7F23E-6E67-44B5-8975-959897890643Q38005607-F81985F8-2714-4BB3-8DB7-5D4B26F7F9F7Q38007911-2126F81C-3F87-48A5-8334-C3F86579D4E9Q38014896-A93C2C7C-4C68-4D52-8321-6AF137E2A857Q38059103-C45A7658-8A94-4430-A927-280423D182A1Q38107439-2ABBAA30-F5AA-42F6-9A01-63DCF529AF70Q38210852-21AB87DD-F1CF-407B-8420-F4033C1DB9C0Q38332493-CF085404-61B6-449A-9EF7-B9A3FE6F689FQ38396129-D644D7A1-71BC-423E-A12E-BAD7B92CC4F0Q38577907-F86D4CD3-5CB1-467C-B830-553168043E28Q38628957-57C2D316-A994-406E-AF1F-E1046500E890Q38709211-FB3D27F0-E0CA-4C1B-BBD3-161CA088F8BCQ38749688-2EF570B8-FAA4-404A-AD4F-68D0E40E9B7DQ38897776-D22FFA2B-2B88-4308-8124-C09E2B0629E1Q39097864-AD9DE0BF-BAB2-4746-9F80-BA4D7AB78E55Q39446547-13D781DA-D2AA-4B87-8046-E34A0BB08F8DQ40882750-65B16EF0-89CF-43C8-80A5-1DA3E178CA9C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Stem cell technology for neurodegenerative diseases.
@ast
Stem cell technology for neurodegenerative diseases.
@en
type
label
Stem cell technology for neurodegenerative diseases.
@ast
Stem cell technology for neurodegenerative diseases.
@en
prefLabel
Stem cell technology for neurodegenerative diseases.
@ast
Stem cell technology for neurodegenerative diseases.
@en
P2860
P356
P1433
P1476
Stem cell technology for neurodegenerative diseases
@en
P2093
J Simon Lunn
Stacey A Sakowski
P2860
P304
P356
10.1002/ANA.22487
P577
2011-09-01T00:00:00Z